Related Experiment Video
Updated: Jul 6, 2026

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
Published on: March 23, 2018
Is blood cardioplegia superior to crystalloid cardioplegia?
Samuel Jacob1, Antonios Kallikourdis, Frank Sellke
1Department of Cardio-thoracic Surgery, Aberdeen Royal Infirmary, Aberdeen, AB25 2ZN, UK.
Insights
Blood cardioplegia may offer benefits in reducing low output syndrome and enzyme release compared to crystalloid cardioplegia for myocardial protection. However, evidence is mixed, with some studies showing no clinical differences and others highlighting potential neurological risks with warm blood cardioplegia.
Area of Science:
- Cardiac Surgery
- Cardiovascular Research
- Myocardial Protection Strategies
Background:
- The optimal cardioplegia solution for myocardial protection during cardiac surgery remains a subject of debate.
- Blood cardioplegia and crystalloid cardioplegia are the primary methods employed, each with potential advantages and disadvantages.
- Variations in cardioplegia delivery techniques (e.g., temperature, composition, administration route) complicate direct comparisons.
Purpose of the Study:
- To critically evaluate the clinical superiority of blood cardioplegia versus crystalloid cardioplegia for myocardial protection.
- To synthesize the best available evidence from randomized trials to guide clinical practice.
Main Methods:
- A structured review of 501 identified papers, selecting 22 representing the best evidence.
- Analysis focused on randomized trials comparing blood and crystalloid cardioplegia, considering various delivery methods and patient factors.
- Key outcomes included low output syndrome, enzyme release (CK-MB), myocardial infarction, mortality, and neurological events.
Main Results:
- A meta-analysis of 34 trials suggested lower incidence of low output syndrome and CK-MB release with blood cardioplegia, but was confounded by data limitations.
- Large randomized trials showed no significant clinical differences between cold blood and crystalloid cardioplegia (Ovrum, 2006).
- One study reported increased neurological events with warm blood cardioplegia (Martin, 1994), leading to early cessation.
- Of 18 other randomized trials, 10 favored blood cardioplegia for clinical outcomes, and 5 for enzyme release.
Conclusions:
- The evidence comparing blood and crystalloid cardioplegia is complex due to technique variations.
- While some studies indicate potential benefits of blood cardioplegia for specific outcomes, definitive superiority is not established.
- Current UK practice reflects a diverse approach, with a majority of surgeons utilizing cold blood cardioplegia, aligning with some supportive findings.
Abstract:
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether blood cardioplegia is clinically superior to crystalloid cardioplegia for myocardial protection. Altogether 501 papers were identified. We selected 22 papers that represented the best evidence to answer the question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. This is a difficult topic to review, as the techniques studied in the many trials performed vary widely. Factors which may vary include warm or cold blood cardioplegia, antegrade and retrograde administration, systemic hypothermia or normothermia, topical heart cooling, high and low potassium solutions, 'hot shots', warm induction, volume of cardioplegia, patient factors and bypass times. However, three papers stand out. The meta-analysis of 34 randomised trials by Prof Fremes (2006) found a significantly lower incidence of low output syndrome (LOS) and CK-MB release with blood cardioplegia. He found no differences in myocardial infarction or mortality. This meta-analysis was confounded, however, by the fact that he was unable to extract data on LOS and CK-MB from the two largest trials which contributed over half the patients in his paper and are significantly larger than all other studies. The first paper by Ovrum (2006) randomised 1440 patients to antegrade cold blood or crystalloid and found no clinical differences, and the second paper by Martin (1994) of 1001 patients compared warm blood to cold crystalloid but the study had to be stopped due to a high incidence of neurological events in the warm blood group. We reviewed a further 18 randomised trials reporting over 50 patients. Of these, 10 reported some statistically significant clinical outcomes in favour of blood cardioplegia and five reported statistically significant differences in enzyme release in favour of blood cardioplegia. A recent survey of UK practice found that 56% of surgeons use cold blood cardioplegia, 14% use warm blood cardioplegia, 14% use crystalloid cardioplegia, 21% use retrograde infusion and 16% do not use any cardioplegia. The papers presented in our review support most of these practices!
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: Inotropic Agents
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy VII: Pre and Post Operative Nursing Management

